InvestorsHub Logo
Followers 7
Posts 255
Boards Moderated 0
Alias Born 03/07/2004

Re: geocappy1 post# 216887

Saturday, 04/25/2015 2:03:22 PM

Saturday, April 25, 2015 2:03:22 PM

Post# of 346054
I'm under the impression that Opdivo Phase III trial is for squamous NSCLC. If this is the case, how would FDA approval of Opdivo affect approval of Bavi, which is for non-squamous treatment?

TIA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News